x

Cerca un progetto di ricerca

* (*) campo obbligatorio

207 Risultato/i

Ordinato per

Progetti di ricerca terminati = Finanziato da un ente associato a IRDiRC = Membro di una ERN =

Progetti di ricerca

BELGIO

VLAAMS BRABANT
LEUVEN

HDACALS: Investigating the therapeutic potential of inhibition of histone deacetylases in a FUS mouse model of ALS
UZ Leuven - Campus Gasthuisberg
Ludo Van Den Bosch Lab- VIB-KU Leuven Center for Brain & Disease Research

CANADA

Alberta
EDMONTON

Finanziato da un ente associato a IRDiRCMRI biomarkers in ALS
University of Alberta
Department of Medicine, Division of Neurology

CANADA

Alberta
EDMONTON

Finanziato da un ente associato a IRDiRCPromoting protection of functionally intact motor units in amyotrophic lateral sclerosis (ALS).
University of Alberta
Faculty of Physical Education and Recreation

CANADA

Colombie-Britannique
VANCOUVER

CANADA

Ontario
OTTAWA

Finanziato da un ente associato a IRDiRCLoss of VAPB Function in Amyotrophic Lateral Sclerosis-8 (ALS8)
Ottawa Hospital Research Institute
Neuroscience

CANADA

Ontario
TORONTO

Finanziato da un ente associato a IRDiRCThe TAR DNA-Binding Protein (TDP-43) and Amyotrophic Lateral Sclerosis
University of Toronto
Centre for Research in Neurodegenerative Disease

CANADA

Ontario
WATERLOO

Finanziato da un ente associato a IRDiRCFolding and aggregation of ALS-associated mutant superoxide dismutases
University of Waterloo
Department of Chemistry

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCUnderstanding G3BP1 and stress granule dynamics in ALS pathogenesis
Centre Hospitalier de l'Université de Montréal
Département de biochimie et médecine moléculaire

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCRegeneration of motor neurons controlling movement and respiration from embryonic stem cells
Montreal Neurological Institute and Hospital
McGill University

CANADA

Québec
MONTRÉAL

Finanziato da un ente associato a IRDiRCRegulation of motor neuron identity and circuit development
Montreal Neurological Institute and Hospital
McGill University

CANADA

Québec
MONTRÉAL

FINLANDIA

Finland
HELSINKI

Finanziato da un ente associato a IRDiRCCDNF and CDNF variants- novel therapy for ALS
Biocenter 1, University of Helsinki
Institute of Biotechnology

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

GRAND-EST
ILLKIRCH-GRAFFENSTADEN

Finanziato da un ente associato a IRDiRCC9ORF72-ALS: Role of C9ORF72 in Amyotrophic Lateral Sclerosis
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique

FRANCIA

GRAND-EST
ILLKIRCH-GRAFFENSTADEN

Finanziato da un ente associato a IRDiRCStudy of new mutations in the C9ORF72 gene responsible for Amyotrophic Lateral Sclerosis
Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
Département Médecine translationnelle et neurogénétique

FRANCIA

GRAND-EST
STRASBOURG

Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
Faculté de médecine de Strasbourg - Louis Pasteur
Laboratoire de signalisations moléculaires et neurodégénérescence

FRANCIA

GRAND-EST
STRASBOURG

Finanziato da un ente associato a IRDiRCRole of CA-repeating microsatellites in FUS and TDP-43 related diseases
Faculté de médecine de Strasbourg - Louis Pasteur
Mécanismes centraux et périphériques de la Neurodégénérescence - INSERM U1118

FRANCIA

GRAND-EST
STRASBOURG

Finanziato da un ente associato a IRDiRCMuscle contribution to FUS-associated ALS: genetic and mechanistic insights - FR
Faculté de médecine de Strasbourg - Louis Pasteur
Mécanismes centraux et périphériques de la Neurodégénérescence - INSERM U1118

FRANCIA

GRAND-EST
STRASBOURG

Finanziato da un ente associato a IRDiRCDeciphering the mechanisms of repeat-associated non-AUG (RAN) translation in amyotrophic lateral sclerosis
IBMC - Institut de biologie moléculaire et cellulaire
Evolution des Systèmes d'Initiation de la Traduction chez les eucaryotes

FRANCIA

GRAND-EST
STRASBOURG

Finanziato da un ente associato a IRDiRCMAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - FR
Institut Pluridisciplinaire Hubert Curien
Spectrométrie de masse bio organique

FRANCIA

HAUTS-DE-FRANCE
LILLE

Finanziato da un ente associato a IRDiRCAssessment of the ethical and legal issues of the use of telemedicine in the support of patients with advanced stage Amyotrophic lateral sclerosis
GH de l'Institut Catholique de Lille - Hopital Saint Vincent de Paul
Institut catholique de Lille - ICL ETHICS EA 7446

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCCell signaling, Reinnervation and Metabolism in Amyotrophic Lateral Sclerosis (CERMALS)
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Unité Nerf périphérique, Sclérose Latérale Amyotrophique (SLA)

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCEfficacy, activity and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
APHP.Sorbonne Université, Hôpital de la Pitié-Salpêtrière

FRANCIA

ILE-DE-FRANCE
PARIS

Involvement of metabolic dysfunctions in the pathogenesis of amyotrophic lateral sclerosis
AP-HP.Sorbonne Université - Hôpital de la Pitié-Salpêtrière
Département de Neurologie - Pôle des Maladies du Système Nerveux

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCNew gene therapy approaches for familial forms of amyotrophic lateral sclerosis
Institut de Myologie - Hôpital Pitié-Salpêtrière
Centre de Recherche en Myologie

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCAAV-mediated delivery of FGF as a therapeutic strategy for Amyotrophic Lateral Sclerosis
Institut de Myologie - Hôpital Pitié-Salpêtrière
Centre de Recherche en Myologie

FRANCIA

ILE-DE-FRANCE
PARIS

Study of the interactions between microglial cells, macrophages and neurons from three axes in an animal model of amyotrophic lateral sclerosis
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Bases moléculaires, physiopathologie et traitement des maladies neurodégénératives"

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCDeciphering respective contributions of macrophages and microglia to motor neuron degeneration in Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis with microfluidic devices
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Causes de la SLA et mécanismes de la dégénérescence motoneuronale"

FRANCIA

ILE-DE-FRANCE
PARIS

Localisation and identification of causative genes for amyotrohic lateral sclerosis
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Excitabilité, synapse & pathologies associées"

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCAmyotrophic Lateral Sclerosis gene therapy by restoring neuronal cholesterol metabolism
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Institut du Cerveau et de la Moëlle épinière - INSERM U1127

FRANCIA

ILE-DE-FRANCE
PARIS CEDEX 06

Finanziato da un ente associato a IRDiRCThe effect of autophagy induction on the neuromuscular junction in ALS
Centre de Neurophysique, Physiologie et Pathologie - CNRS UMR 8119
Développement et pathologies des jonctions neuromusculaires

FRANCIA

NOUVELLE AQUITAINE
BORDEAUX

Finanziato da un ente associato a IRDiRCChloride-related inhibition in spinal motoneurons during the ALS disease progression in mouse model
Université Bordeaux 2 - Victor Ségalen
Institut de Neurosciences Cognitives et Intégratives - CNRS UMR 5287

FRANCIA

NOUVELLE AQUITAINE
BORDEAUX

Finanziato da un ente associato a IRDiRCThe P2X4 receptor: a key player in Amyotrophic Lateral Sclerosis and a biomarker
Université Bordeaux 2 - Victor Ségalen
Institut des Maladies Neurodégénératives (IMN) - CNRS UMR 5293

FRANCIA

OCCITANIE
MONTPELLIER

Finanziato da un ente associato a IRDiRCSpread and Toxicity of Pathogenic Factors in Amyotrophic Lateral Sclerosis
CHU de Montpellier - Hôpital Saint-Eloi
Institut des Neurosciences de Montpellier - INSERM U1051

FRANCIA

OCCITANIE
MONTPELLIER

Finanziato da un ente associato a IRDiRCAAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis - FR
CHU de Montpellier - Hôpital Saint-Eloi
Institut des Neurosciences de Montpellier - INSERM U1051

FRANCIA

OCCITANIE
MONTPELLIER

Finanziato da un ente associato a IRDiRCDetermine how local translation of mRNA impacts neurodegenerative diseases
UMR5535 Institut de génétique moléculaire de Montpellier (IGMM)
Assemblage et Trafic de Ribonucléoprotéines

FRANCIA

OCCITANIE
MONTPELLIER CEDEX 05

Finanziato da un ente associato a IRDiRCDeciphering the beneficial effects of Sigma-1 receptor in amyotrophic lateral sclerosis
Mécanismes moléculaires dans les démences neurodégénératives (MMDN)
MMDN - Mécanismes Moléculaires dans les Démences Neurodégénératives

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Finanziato da un ente associato a IRDiRCG4C2 Repeat Sizing by Bionano Optical Mapping
Université de médecine Aix-Marseille Université
Institut des Neurosciences de la Timone

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
NICE

Finanziato da un ente associato a IRDiRCIn vivo and in vitro direct lineage reprogramming of neuronal and somatic cells to corticospinal motor neurons
Université de Nice Sophia-Antipolis - Faculté des sciences
iBV - Institut de Biologie Valrose

GERMANIA

Baden-Württemberg
ULM

Finanziato da un ente associato a IRDiRCREPETOMICS: Genomic Instability of Expanded Repeats in HD and ALS/FTD -DE
Universitäts- und Rehabilitationskliniken Ulm (RKU)
Klinik für Neurologie

GERMANIA

Bayern
MARTINSRIED/PLANEGG

Finanziato da un ente associato a IRDiRCMAIV: Interdisciplinary consortium for the establishment of an in vitro disease model of ASL
BioMedical Center - BMC
Department of Physiological Genomics

GERMANIA

Bayern
WÜRZBURG

Finanziato da un ente associato a IRDiRCCALSER : The effect of CDNF in ALS and ER stress (partner no 2)
Institut für Klinische Neurobiologie der Universität Würzburg
Institut für Klinische Neurobiologie

GERMANIA

Nordrhein-Westfalen
BONN

GERMANIA

Nordrhein-Westfalen
BONN

Finanziato da un ente associato a IRDiRCMAXOMOD: Multi-omic analysis of axono-synaptic degeneration in motoneuron disease - coordination, biomaterials and biomarkers -DE
Projektträger im Deutschen Zentrum für Luft- und Raumfahrt
ERA-Net for research programs on rare diseases - Germany

IRLANDA

County Dublin
DUBLIN

EEG and TMS-based Biomarkers of ALS, MS and FTD
Trinity College Dublin
Department of Neurology - Trinity Biomedical Sciences Institute

IRLANDA

County Dublin
DUBLIN

ISRAELE

ISRAEL
REHOVOT

Finanziato da un ente associato a IRDiRCRigorous, integrated miRNA-DNA plasma biomarkers for amyotrophic lateral sclerosis
Arnold R. Meyer Institute of Biological Sciences, Weizmann Institute of Science
Department of Molecular Genetics

ISRAELE

ISRAEL
TEL AVIV

Finanziato da un ente associato a IRDiRCALS-degeneration: The molecular basis for neurodegeneration and muscle atrophy in ALS - IL
University of Tel-Aviv
Dept. of Physiology and Pharmacology

ITALIA

LAZIO
ROMA

Proposta per un approccio integrato allo studio delle malattie rare: dai modelli di base di laboratorio alla epidemiologia clinica della sclerosi laterale amiotrofica (ALS)
ISS - Istituto Superiore di Sanità
Reparto Farmaci per la Salute del Bambino e della Donna - Dipartimento del Farmaco

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCRegistro della Sclerosi Laterale Amiotrofica (SLA) nella Regione Lazio
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Prevenzione delle Malattie e la Promozione della Salute

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCExosomal RNA for the diagnosis of ALS
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCFollowing drug repurposing strategy: Preclinical assessment of new potential therapeutic target/drug in the SOD1G93A mouse model
ISS - Istituto Superiore di Sanità
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCUncovering the function of HDAC4 in skeletal muscle
Sapienza Università di Roma - Sezione di Ricerca "Valdoni Lab"
Dipartimento di Scienze Anatomiche, Istologiche, Medico Legali e dell'Apparato Locomotore

ITALIA

LOMBARDIA
MILANO

Vulnerabilità modulante dei motoneuroni utilizzando i geni ristretti oculomotore IGF-2 e SYT13 per la terapia della SLA
Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico
Dipartimento di Scienze Neurologiche

ITALIA

LOMBARDIA
MILANO

Finanziato da un ente associato a IRDiRCStudi preclinici mirati allo sviluppo di terapie geniche per il trattamento della sclerosi laterale amiotrofica
Istituto di Ricerche Farmacologiche "Mario Negri"
Laboratorio di Neurobiologia Molecolare

ITALIA

LOMBARDIA
PAVIA

Finanziato da un ente associato a IRDiRCNuove strategie terapeutiche per la cura dell'Atrofia Muscolare Spinale: valutazione dell'efficacia di peptidi cellula-permeabili in modelli preclinici
Istituti Clinici Scientifici Maugeri IRCCS
Laboratorio di Ricerca sulle malattie Neurodegenerative

ITALIA

PIEMONTE
TORINO

Finanziato da un ente associato a IRDiRCMutazioni nel gene MATR3 causano Sclerosi Laterale Amiotrofica (SLA)
Ospedale Molinette
Centro regionale esperto per la sclerosi laterale amiotrofica

ITALIA

PUGLIA
BARI

Sclerosi laterale amiotrofica (SLA) e deficienze multiple delle Acil-CoA deidrogenasi riboflavina responsive (RR-MADD)
Università degli Studi di Bari Aldo Moro
Laboratorio di Biochimica e Biologia Molecolare E.Quagliarello

PORTOGALLO

SUL
LISBOA

Respiratory Rehabilitation in Amyotrophic Lateral Sclerosis: clinical and biochemical impact.
Faculdade de Medicina da Universidade de Lisboa
Unidade de Neuromusculares

PORTOGALLO

SUL
OEIRAS

Mechanisms of SOD1 toxic aggregation in neurodegenerative processes
Instituto de Tecnologia Química e Biológica
Protein Biochemistry Folding and Stability

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Investigating neuronal RNA localisation and translational deficits as gain of function mechanisms in ALS.
UCL Institute of Neurology, University College London,
Clinical Neurosciences

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

REGNO UNITO; GRAN BRETAGNA

Oxfordshire
OXFORD

Antisense Oligonucleotide Therapy for Neuromuscular Disease
University of Oxford
Department of Physiology, Anatomy and Genetics

SPAGNA

Andalucía
SEVILLA

Functional characterization and mechanisms of the signalling kinase MOK in neuroinfiammation associated to Amyotrophic Lateral Sclerosis (ALS)
CABIMER - Centro Andaluz de Biología Molecular y Medicina Regenerativa
Neuroinmunología celular y molecular

SPAGNA

Canarias
LAS PALMAS DE GRAN CANARIA

Finanziato da un ente associato a IRDiRCUnderstanding TDP-43 central role in ALS and other TDP43 proteinopathies
Hospital Universitario de Gran Canaria Dr. Negrín
FIISC: Fundación Canaria Instituto de Investigación Sanitaria de Canarias

SPAGNA

Castilla - La Mancha
TOLEDO

A potential metabolic-targeted therapeutic for Amyotrophic lateral sclerosis (ALS): Leptin
Hospital Nacional de Parapléjicos
Laboratorio de Neurometabolismo

SPAGNA

Cataluña
LLEIDA

Finanziato da un ente associato a IRDiRCCell stress, lipid metabolism and RNA processing at the crossroad of ALS pathophysiology
Instituto de Investigación Biomédica de Lleida (IRBLLEIDA)
Instituto de Investigación Biomédica de Lleida - IRBLLEIDA

SPAGNA

Madrid
MADRID

Significance of brain glucose hypometabolism and of altered insulin signal transduction in an experimental model of amiotrophic lateral esclerosis (ALE)
Universidad Complutense de Madrid. Facultad de Medicina
Departamento de Bioquímica y Biología Molecular (Medicina)

STATI UNITI

Illinois
CHICAGO

Finanziato da un ente associato a IRDiRCStudying nucleocytoplasmic imbalances to design new therapeutic strategies for amyotrophic lateral sclerosis
Northwestern University Feinberg School of Medicine
Department of pathology

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCModeling the progression of sod1-linked motor neuron disease
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCExtrinsic mechanisms governing injury-induced axon degeneration
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCInvestigating disease mechanisms in c9orf72-linked als/ftd
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCP97 inhibitors for treatment of ibmpfd/als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCMuscle tregs in health and disease
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCAmpk; metabolism and als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCEpigenetic editing of mutant c9orf72
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCInvestigating a2-chimaerin-dependent motor neuron protection in als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCInvestigation of als caused by mutant chchd10
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCMechanisms of hipk2 in neurodegeneration
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCNucleocytoplasmic transport and nuclear pore disruption in als/ftd
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRole of c9orf72 in neurodegeneration
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRole of oligodendroglia in the pathogenesis of als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCStudy on hnrnpa1 pathobiology in als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCDetermination of cell death pathways activated in als
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCOligodendroglial dysfunction in c9orf72 als and ftd
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCStudy on neurodegeneration using tdp-43 transgenic rats
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCFg-nucleoporins and nuclear transport disruption in c9orf72-als/ftd
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCMechanisms of motor neuron disease
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCNad metabolsim and mitochondrial dysfunction in als models
Institution: Information not provided - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCRegulation of glutamate transport in astrocyte subtypes and in als
Institution: Information not provided - US

SVEZIA

Region Skåne
LUND

Finanziato da un ente associato a IRDiRCAAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis
Lund University
Department of Experimental Medical Science

SVEZIA

Region Stockholm
STOCKHOLM

In vitro molecular mechanism of amyotrophic lateral sclerosis
Stockholm University
Department of Biochemistry and Biophysics

SVEZIA

Region Västerbotten
UMEÅ

SVEZIA

Region Västerbotten
UMEÅ

Studies of misfolded SOD1 in amyotrophic lateral sclerosis (ALS)
Umeå University
Department of Medical Biosciences

SVEZIA

Region Västerbotten
UMEÅ

Molecular portfolio of the extraocular muscles: clues to protection in muscular disease
University Hospital of Umeå
Department of Clinical Sciences

SVEZIA

Region Västerbotten
UMEÅ

SVIZZERA

Suisse Alémanique
ZÜRICH

MAXOMOD - Multi-omic analysis of axono-synaptic degeneration in motoneuron disease
Universität Zürich
Functional Genomics Center Zurich

SVIZZERA

Suisse Romande
LAUSANNE

Finanziato da un ente associato a IRDiRCAAV-mediated delivery of FGF as a therapeutic strategy for amyotrophic lateral sclerosis - CH
EPFL - Ecole Polytechnique Fédérale de Lausanne
Bertarelli Platform for Gene Therapy

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

Finanziato da un ente associato a IRDiRCThe extracellular matrix collagen XV as a new player of motor axon development and regeneration: a functional study using zebrafish
Institut de Génomique Fonctionnelle de Lyon
Matrix Biology and Pathology, Managemant

SPAGNA

Cataluña
BARCELONA

Advanced genomics and lipidomics for identifying novel causes of inherited movement disorders
Instituto de Química Avanzada de Cataluña
Unidad de Investigación en Moléculas Bioactivas

SPAGNA

País Vasco
SAN SEBASTIÁN

Advanced genomics and lipidomics for identifying novel causes of inherited movement disorders
Instituto de Investigación Sanitaria Biodonostia
Área de Neurociencias

BELGIO

ANTWERPEN
ANTWERPEN

Finanziato da un ente associato a IRDiRCA preclinical study to treat neuromuscular diseases caused by mutations in the small heat shock protein HSPB8
University of Antwerp - UA, Campus Drie Eiken
Peripheral Neuropathy Research Group

CANADA

Ontario
OTTAWA, ONTARIO

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

FRANCIA

AUVERGNE-RHONE-ALPES
GRENOBLE

Finanziato da un ente associato a IRDiRCEarly identification of respiratory exacerbations using NIV device monitoring in slowly progressive neuromuscular disorders
CHU Grenoble Alpes - Site Nord - Hôpital Couple Enfant
Laboratoire EFCR/Pneumologie

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

Finanziato da un ente associato a IRDiRCInterplay between cell metabolism and alternative splicing
ENS - Ecole normale supérieure de Lyon
Laboratoire de biologie et modélisation de la cellule - UMR5239

FRANCIA

AUVERGNE-RHONE-ALPES
LYON

Finanziato da un ente associato a IRDiRCAmino acid metabolism and alternative splicing
ENS - Ecole normale supérieure de Lyon
Laboratoire de biologie et modélisation de la cellule - UMR5239

FRANCIA

ILE-DE-FRANCE
CRÉTEIL

FRANCIA

ILE-DE-FRANCE
CRÉTEIL

Finanziato da un ente associato a IRDiRCAn integrated translational program for neuromuscular disorders
Hôpitaux Universitaires Henri Mondor
Centre expert de maladie neuro-musculaire

FRANCIA

ILE-DE-FRANCE
GARCHES

Finanziato da un ente associato a IRDiRCPatient-ventilator asynchrony in neuromuscular disease: real life evaluation using devices softwares
CHU Paris IdF Ouest - Hôpital Raymond Poincaré
Service de Physiologie-Explorations Fonctionnelles - Consultations Troubles du sommeil

FRANCIA

ILE-DE-FRANCE
PARIS

FRANCIA

ILE-DE-FRANCE
PARIS

Finanziato da un ente associato a IRDiRCsPAM: Developing peptide-based drugs to target ataxin-2 in neuromuscular disease - FR
Institut du Cerveau et de la Moelle épinière (ICM) - Hôpital Pitié-Salpêtrière
Equipe "Traitement de la sclérose latérale amyotrophique : de la génétique au poisson zèbre"

FRANCIA

PAYS DE LA LOIRE
NANTES

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Finanziato da un ente associato a IRDiRCModelisation and Therapeutic Approaches for Rare Diseases
Université de médecine Aix-Marseille Université
Centre de Génétique de Marseille (Marseille Medical Genetics - MMG)

FRANCIA

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Finanziato da un ente associato a IRDiRCA quantitative MRI platform for simultaneous and automatic quantification of fat infiltration and T2 relaxation times in neuromuscular disorders - FR
Université de médecine Aix-Marseille Université
Centre de Résonance Magnétique Biologique et Médicale

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCMalattie rare causate dalla deregolazione funzionale delle proteine Rho GTPasi
ISS - Istituto Superiore di Sanità
Centro Nazionale Malattie Rare

ITALIA

LAZIO
ROMA

Finanziato da un ente associato a IRDiRCCellular network driving neuromuscular junction stability
Sapienza Università di Roma
Università degli Studi di Roma "La Sapienza"

SPAGNA

Cataluña
BARCELONA

Igenco: In-Depth genomics and cross-omics analysis for undiagnosed rare diseases on a user-friendly collaborative platform
ISGlobal - Instituto de Salud Global de Barcelona
Programa de investigación en Enfermedades no transmisibles y medio ambiente

SPAGNA

Madrid
MADRID

STATI UNITI

California
PALO ALTO

Finanziato da un ente associato a IRDiRCsPAM: Developing peptide-based drugs to target ataxin-2 in neuromuscular disease - US
Stanford University School of Medicine
Department of Genetics

CANADA

Colombie-Britannique
VICTORIA

CANADA

Ontario
TORONTO

SPAGNA

Cataluña
BARCELONA

Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Centro de Regulación Genómica
Archivo europeo de genomas y fenomas del CRG

SPAGNA

Cataluña
BARCELONA

SPAGNA

Cataluña
BARCELONA

SPAGNA

Cataluña
BARCELONA

SPAGNA

Cataluña
L'HOSPITALET DE LLOBREGAT

Catalan Interhospital Network of Genetic Variants to improve genetic diagnosis in rare diseases
Hospital Universitari de Bellvitge
Unidad de Genética Molecular

SPAGNA

Madrid
MADRID

Finanziato da un ente associato a IRDiRCIdentification of new genes causing rare diseases in pediatric patients, searching of genetic pharmacological targets, and drugs discovery, the steps for a personalized medicine
Instituto de Investigación Hospital 12 de Octubre
Grupo de investigación en enfermedades raras, mitocondriales y neuromusculares

STATI UNITI

Washington
ADDRESS: NOT PROVIDED - US

Finanziato da un ente associato a IRDiRCA powerful web-based discovery platform for rare disease genetics
Institution: Information not provided - US

Progetti di ricerca multicentrici